Literature DB >> 22299422

Epidemiology of adult candidemia at Chiang Mai University Hospital.

Romanee Chaiwarith1, Pooriwat Ounbang, Chantana Khamwan, Nontakan Nuntachit, Thira Sirisanthana, Khuanchai Supparatpinyo.   

Abstract

A retrospective study was conducted between July 1, 2004 and June 30, 2009 at Chiang Mai University Hospital among 138 patients with candidemia; 85 patients (61.6%) were male and the mean age was 57.7 +/- 19.4 years. Seventy-eight patients (56.5%) had underlying medical conditions. Candida albicans and non-albicans Candida were identified in 42 (30.4%) and 96 (69.6%) patients, respectively. Not being admitted to the ICU was the only factor associated with non-albicans candidemia (p = 0.018). Sixty patients (43.5%) had favorable outcomes. Factors independently associated with unfavorable outcomes included patients who were in the ICU (p = 0.025), were intubated (p < 0.001) or were on hemodialysis (p = 0.031); prior abdominal surgery was associated with a favorable outcome (p = 0.026). Candidemia is not a rare condition at this hospital. Early recognition and prompt empirical treatment are essential to improve outcomes of patients at risk for developing candidemia. Improvement of surveillance is crucial to recognizing emergence of highly resistant strains of Candida spp.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22299422

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.

Authors:  Hugo Dias Hoffmann-Santos; Claudete Rodrigues Paula; Ana Caroline Akeme Yamamoto; Tomoko Tadano; Rosane C Hahn
Journal:  Mycopathologia       Date:  2013-10-11       Impact factor: 2.574

2.  Wss1 homolog from Candida albicans and its role in DNA-protein crosslink tolerance.

Authors:  Aimorn Homchan; Juthamas Sukted; Skorn Mongkolsuk; David Jeruzalmi; Oranart Matangkasombut; Danaya Pakotiprapha
Journal:  Mol Microbiol       Date:  2020-05-13       Impact factor: 3.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.